Unknown

Dataset Information

0

Improved antitumor activity of TRAIL fusion protein via formation of self-assembling nanoparticle.


ABSTRACT: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been known as a promising agent for cancer therapy due to its specific apoptosis-inducing effect on tumor cells rather than most normal cells. However, systemically delivered TRAIL suffers from a rapid clearance from the body with an extremely short half-life. Thermally responsive elastin-like polypeptides (ELPs) are a promising class of temperature sensitive biopolymers based on the structural motif found in mammalian tropoelastin and retain the advantages of polymeric drug delivery systems. We therefore expressed RGD-TRAIL fused with ELP (RGD-TRAIL-ELP) in E. coli. Purification of RGD-TRAIL-ELP was achieved by the conveniently inverse transition cycling (ITC). The purified RGD-TRAIL-ELP without any chemical conjugation was able to self-assemble into nanoparticle under physiological condition. Non-reducing SDS-PAGE results showed that trimer content of RGD-TRAIL-ELP increased 3.4-fold than RGD-TRAIL. Flow cytometry confirmed that RGD-TRAIL-ELP 3-fold enhanced apoptosis-inducing capacity than RGD-TRAIL. Single intraperitoneal injection of the RGD-TRAIL-ELP nanoparticle induced nearly complete tumor regression in the COLO-205 tumor xenograft model. Histological observation confirmed that RGD-TRAIL-ELP induced significant tumor cell apoptosis without apparent liver toxicity. These findings suggested that a great potential application of the RGD-TRAIL-ELP nanoparticle system as a safe and efficient delivery strategy for cancer therapy.

SUBMITTER: Huang K 

PROVIDER: S-EPMC5320504 | biostudies-literature | 2017 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Improved antitumor activity of TRAIL fusion protein via formation of self-assembling nanoparticle.

Huang Kaizong K   Duan Ningjun N   Zhang Chunmei C   Mo Ran R   Hua Zichun Z  

Scientific reports 20170222


Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been known as a promising agent for cancer therapy due to its specific apoptosis-inducing effect on tumor cells rather than most normal cells. However, systemically delivered TRAIL suffers from a rapid clearance from the body with an extremely short half-life. Thermally responsive elastin-like polypeptides (ELPs) are a promising class of temperature sensitive biopolymers based on the structural motif found in mammalian tropoelas  ...[more]

Similar Datasets

| S-EPMC5143403 | biostudies-literature
| S-EPMC7259527 | biostudies-literature
| S-EPMC4401500 | biostudies-literature
| S-EPMC2735593 | biostudies-literature
| S-EPMC8312026 | biostudies-literature
| S-EPMC11348728 | biostudies-literature
| S-EPMC5566391 | biostudies-literature
| S-EPMC5414263 | biostudies-literature
| S-EPMC4597189 | biostudies-literature
| S-EPMC5969494 | biostudies-literature